Fox Run Management’s CytomX Therapeutics CTMX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,149	Closed	-$225K	–	550
2018 Q3	$225K	Buy	+12,149	New	+$225K	0.1%	444
2018 Q2	–	Sell	-15,446	Closed	-$439K	–	709
2018 Q1	$439K	Buy	+15,446	New	+$439K	0.11%	352